8:30-10:00am– Grand Rounds Lecture: Dr. Katherine Uyhazi, MD, PhD, “Regenerating the Retina: Gene and Cell Therapies for LCA5-LCA”
Learning Objectives:
- To understand the pathophysiology of Leber congenital amaurosis caused by mutations in the Lebercilin (LCA5) gene.
- To review interim results of a Phase I/II Gene Replacement Therapy Trial for Patients with LCA5-LCA.
- To understand cell-based approaches for photoreceptor cell replacement in late stage retinal diseases.
Disclosures: Presenter Dr. Katherine Uyhazi, ND, PhD has no financial relationships to disclose.
Planner Yvonne Ou, MD advises for Oculinea.
Target Audience: Physicians and Advanced Practice Providers.
Accreditation: The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. UCSF designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity. You must complete an evaluation to qualify for CME credit.
Designation: UCSF designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This presentation receives support from UCSF’s (non-commercial) Samuel J. Kimura Fund, Transamerica Lecture Fund and Proctor Lecture Fund.